Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,954 | -9,361 | -1,339 | -35,399 | -23,281 |
| Depreciation Amortization | 28 | 19 | 9 | 42 | 33 |
| Accounts payable and accrued liabilities | -3,651 | -773 | 171 | 12 | -1,376 |
| Other Working Capital | -4,170 | -1,355 | -561 | 811 | -1,086 |
| Other Operating Activity | 2,734 | -1,212 | -2,678 | 2,935 | 2,628 |
| Operating Cash Flow | $-18,013 | $-12,682 | $-4,398 | $-31,599 | $-23,081 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 10,022 | 10,022 |
| PPE Investments | N/A | N/A | N/A | -37 | -37 |
| Other Investing Activity | -379 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-379 | $N/A | $N/A | $9,985 | $9,985 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 347 | N/A | N/A | 15,672 | N/A |
| Financing Cash Flow | $347 | $N/A | $N/A | $15,672 | $N/A |
| Exchange Rate Effect | 12 | 24 | 73 | -50 | -29 |
| Beginning Cash Position | 28,107 | 28,249 | 28,249 | 34,241 | 34,099 |
| End Cash Position | 10,073 | 15,591 | 23,924 | 28,249 | 20,974 |
| Net Cash Flow | $-18,033 | $-12,658 | $-4,325 | $-5,992 | $-13,125 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,013 | -12,682 | -4,398 | -31,599 | -23,081 |
| Capital Expenditure | N/A | N/A | N/A | -37 | -37 |
| Free Cash Flow | -18,013 | -12,682 | -4,398 | -31,636 | -23,118 |